Theravance Biopharma, Inc.·4

May 22, 6:19 PM ET

WORBOYS PHILIP D 4

4 · Theravance Biopharma, Inc. · Filed May 22, 2019

Insider Transaction Report

Form 4
Period: 2019-05-20
WORBOYS PHILIP D
SVP, Translational Science
Transactions
  • Tax Payment

    Ordinary Shares

    2019-05-20$19.84/sh2,272$45,076269,399 total
Footnotes (1)
  • [F1]Includes 1,027 shares acquired under the Theravance Biopharma, Inc. 2013 Employee Share Purchase Plan on May 15, 2019.

Documents

1 file
  • 4
    edgar.xmlPrimary

    FORM 4 -